Autoimmune Viral Trio Panel Explained by Dr. Aristo Vojdani PHD

Interviewer (00:00):
Good morning, Dr. Woods Dani. Good morning. I recently heard that you came out with a new test called the auto immune viral trio panel. Can you tell me a little bit about this test?

Dr. Vojdani (00:12):
Um, as you know, uh, many environmental factors play a role in development of autoimmune diseases and viruses are major contributors to auto immune diseases, especially the three viruses Epstein-Barr virus, herpes type six and SARS cov two, which are part of the viral trio play a significant role in 15 different auto immune diseases.

Interviewer (00:54):
Okay. So how old is test benefit? The patients,

Dr. Vojdani (00:59):
Um, that we know that autoimmune diseases or to develop an auto-immune disease takes between two to 19 years. Some auto-immune diseases takes about two years. Some it takes about 19 years and therefore there is a window of opportunity for intervention by the practitioners to take care of their patients. So by measuring antibodies against these three viruses, EBV herpes type six and SARS cov two, and showing that the patient is having high levels of antibodies against this by intervening in this process, meaning detecting auto immune reactivity, which is different from auto immune disease practitioner will be able to prevent autoimmune disease in the future.

Interviewer (02:17):
Okay. In your opinion, why should someone get this test done?

Dr. Vojdani (02:23):
The auto-immune the viral, your panel is recommended actually for everyone who is having concern about auto-immune diseases. There are many individuals who are having genetic background for auto immune diseases. Secondly, there are many individuals also have history of exposure to environmental factors, including the viruses, particularly Epstein-Barr virus, herpes type six and SARS cov two. And so did detection of high levels of antibodies against these viral three-year-old will help practitioners to implement preventive measures and hopefully to stop the progression of auto-immune diseases in the future.

Interviewer (03:41):
Okay. Thank you so much for your time today.

Related Posts